© 2019 Future Science Group

Unitec House, 2 Albert Place,

London, N3 1QB, UK

Email: info@future-science-group.com
Tel: +44 (0)20 8371 6090

  • LinkedIn - White Circle
  • Facebook - White Circle
  • Twitter - White Circle
  • YouTube - White Circle

News

12 October 2018
Meet the winner of the 2018 Future Science Early Career Research Award

Future Science Group (FSG) today announced the winner of the Future Science Early Career Research Award 2018. Dr Viviana Mucci was chosen by a combination of our expert judging panel and the public vote.

 

Viviana is a researcher in neuro-otology at the University of Antwerp (Belgium). She completed her PhD in July 2018, and is investigating Mal de Debarquement Syndrome, a rare and heretofore little understood vestibular disorder.

 

“I feel very privileged and honored to have had the opportunity to participate in the Early Career Research Award 2018 for Future Science,” commented Viviana. “I would like to extend my most sincere thanks to those who voted for me and those who have supported me, in particular Dr Cherylea Browne”.

 

“My intention when I applied was to help me to grow in the field of vestibular research and to attract more funding opportunities,” she continued. “I am very thankful to Future Science for the opportunity to raise awareness about my research on the rare condition of Mal de Debarquement Syndrome."

 

The award, supported by the journal Future Science OA, aims to recognize outstanding, highly talented and motivated researchers within the first 5 years of their first career position (in academia or industry), who are set to have a big impact in their field. This year’s winner will receive membership of the Future Science OA early career advisory panel, a webinar to present their work, and a monetary prize, among other prizes.

 

More information about Viviana and the other four finalists is available at http://bit.ly/FSECRA18.

 

About Future Science OA

 

Launched in March 2015, Future Science OA is a peer-reviewed, open access, biomedicine and biotechnology journal from the Future Science Group. Its articles present the latest research, putting them into context for the future, and are published using a CC-BY license. Alongside research, the journal features review articles, editorials and perspectives, providing readers with a leading source of commentary and analysis.

About Future Science Group

 

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological, and scientific research. FSG’s portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

 

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.